TD Cowen raised the firm’s price target on Addus HomeCare (ADUS) to $140 from $139 and keeps a Buy rating on the shares. The firm updated its model following Q3 results.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS:
- Addus HomeCare Reports Strong Q3 2025 Results
- Addus Homecare: Strategic Growth and Strong Financial Performance Justify Buy Rating
- Addus HomeCare Q3 2025 Earnings: Growth Amid Challenges
- Addus HomeCare price target raised to $117 from $111 at Barclays
- Addus HomeCare Reports Strong Q3 2025 Financial Results